Treatment of intracranial vasospasm following subarachnoid hemorrhage

Frontiers in Neurology

Volumn 5 MAY, Issue , 2014, Pages

  Bauer, Andrew M ^a   Rasmussen, Peter A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Balloon angioplasty; Cerebral aneurysm; Cerebral vasospasm; Delayed ischemic neurologic deficit; Subarachnoid hemorrhage

Indexed keywords

CLAZOSENTAN; ENDOTHELIN 1 DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM; NICARDIPINE; NIMODIPINE; PAPAVERINE; PLACEBO; TAK 044; VERAPAMIL;

ANASTOMOSIS; BRAIN ANGIOGRAPHY; BRAIN BLOOD FLOW; BRAIN OXYGEN CONSUMPTION; BRAIN VASOSPASM; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUOUS INFUSION; DELAYED ISCHEMIC NEUROLOGIC DEFICIT; DIAGNOSTIC PROCEDURE; DRUG DOSE INCREASE; HEMODILUTION; HUMAN; HYPERTENSION; HYPERVOLEMIA; INTRACRANIAL PRESSURE; NEUROLOGIC DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROPHYLAXIS; REVIEW; SUBARACHNOID HEMORRHAGE; TIME TO TREATMENT; TRANSCRANIAL DOPPLER; TREATMENT INDICATION;

EID: 84904421391     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00072     Document Type: Review

References (62)

1. Linn F, Rinkel G, Algra A, Van Gijn J. Incidence of subarachnoid hemorrhage role of region, year, and rate of computed tomography: a meta-analysis. Stroke (1996) 27(4):625-9. doi: 10.1161/01.STR.27.4.625
2. Bederson JB, Connolly ES, Batjer HH, Dacey RG, Dion JE, Diringer MN, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, American heart association. Stroke (2009) 40(3):994-1025. doi:10.1161/STROKEAHA.108.191395
3. Solomon RA, Fink ME, Lennihan L. Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery (1988) 23(6):699-704. doi:10.1097/00006123-198812000-00002
4. Al-Tamimi YZ, Orsi NM, Quinn AC, Homer-Vanniasinkam S, Ross SA. A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. World Neurosurg (2010) 73(6):654-67. doi:10.1016/j.wneu.2010.02.005
5. Kassell NF, Boarini DJ, Adams HP Jr, Sahs AL, Graf CJ, Torner JC, et al. Overall management of ruptured aneurysm: comparison of early and late operation. Neurosurgery (1981) 9(2):120-8. doi:10.1227/00006123-198108000-00002
6. SIXTH International Congress of Radiology; 1950 July 23-29; London: Radiography (1949) 15(180):282.
7. Ecker A, Riemenschneider PA. Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms. J Neurosurg (1951) 8(6):660-7. doi:10.3171/jns.1951.8.6.0660
8. Allcock JM, Drake CG. Ruptured intracranial aneurysms-the role of arterial spasm. J Neurosurg (1965) 22:21-9. doi:10.3171/jns.1965.22.1.0021
9. Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. J Neurosurg (1978) 48(2):173-8. doi:10.3171/jns.1978.48.2.0173
10. Kassell NF, Torner JC, Jane JA, Haley EC, Adams HP. The international cooperative study on the timing of aneurysm surgery. Part 2: surgical results. J Neurosurg (1990) 73(1):37-47. doi:10.3171/jns.1990.73.1.0037
11. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery (1980) 6(1):1-9. doi:10.1227/00006123-198001000-00001
12. Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke (2001) 32(9):2012-20. doi:10.1161/hs0901.095677
13. Washington CW, Zipfel GJ. Participants in the international multi-disciplinary consensus conference on the critical care management of subarachnoid hemorrhage. Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature. Neurocrit Care (2011) 15(2):312-7. doi:10.1007/s12028-011-9594-8
14. Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, et al. Assessment: transcranial Doppler ultrasonography: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology (2004) 62(9):1468-81. doi:10.1212/WNL.62.9.1468
15. Anderson GB, Ashforth R, Steinke DE, Findlay JM. CT angiography for the detection of cerebral vasospasm in patients with acute subarachnoid hemorrhage. AJNR Am J Neuroradiol (2000) 21(6):1011-5.
16. Otawara Y, Ogasawara K, Ogawa A, Sasaki M, Takahashi K. Evaluation of vasospasm after subarachnoid hemorrhage by use of multislice computed tomographic angiography. Neurosurgery (2002) 51(4):939-42. doi:10.1097/00006123-200210000-00015
17. Yoon DY, Choi CS, Kim KH, Cho B-M. Multidetector-row CT angiography of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: comparison of volume-rendered images and digital subtraction angiography. AJNR Am J Neuroradiol (2006) 27(2):370-7.
18. Greenberg ED, Gold R, Reichman M, John M, Ivanidze J, Edwards AM, et al. Diagnostic accuracy of CT angiography and CT perfusion for cerebral vasospasm: a meta-analysis. AJNR Am J Neuroradiol (2010) 31(10):1853-60. doi:10.3174/ajnr.A2246
19. Velat GJ, Kimball MM, Mocco JD, Hoh BL. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurg (2011) 76(5):446-54. doi:10.1016/j.wneu.2011.02.030
20. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, et al. Cerebral arterial spasm-a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med (1983) 308(11):619-24. doi:10.1056/NEJM198303173081103
21. Pickard JD, Murray GD, Illingworth R. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ (1989) 298(6674):636-42. doi:10.1136/bmj.298.6674.636
22. Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the stroke council, American heart association. Circulation (1994) 90(5):2592-605. doi:10.1161/01.CIR.90.5.2592
23. Haley EC, Kassell NF, Torner JC, Truskowski LL, Germanson TP. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg (1994) 80(5):788-96. doi:10.3171/jns.1994.80.5.0788
24. Webb A, Kolenda J, Martin K, Wright W, Samuels O. The effect of intraventricular administration of nicardipine on mean cerebral blood flow velocity measured by transcranial Doppler in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurocrit Care (2010) 12(2):159-64. doi:10.1007/s12028-009-9307-8
25. Barth M, Capelle HH, Weidauer S, Weiss C, Münch E, Thomé C, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke (2007) 38(2):330-6. doi:10.1161/01.STR.0000254601.74596.0f
26. Thomé C, Seiz M, Schubert GA, Barth M, Vajkoczy P, Kasuya H, et al. Nicardipine pellets for the prevention of cerebral vasospasm. Acta Neurochir Suppl (2011) 110(Pt 2):209-11. doi:10.1007/978-3-7091-0356-2_38
27. Tseng M-Y, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke (2005) 36(8):1627-32. doi:10.1161/01.STR.0000176743.67564.5d
28. Sillberg VAH, Wells GA, Perry JJ. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke (2008) 39(9):2622-6. doi:10.1161/STROKEAHA.107.508341
29. Vergouwen M, Meijers J, Geskus RB. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab (2009) 29(8):1444-53. doi:10.1038/jcbfm.2009.59
30. Chou SH, Smith EE, Badjatia N, Nogueira RG, Sims JR II, Ogilvy CS, et al. A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke (2008) 39(10):2891-3. doi:10.1161/STROKEAHA.107.505875
31. Amin-Hanjani S, Ogilvy CS, Barker FG. Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery (2004) 54(2):326-34. doi:10.1227/01.NEU.0000103488.94855.4F
32. Zabramski JM, Spetzler RF, Lee KS, Papadopoulos SM, Bovill E, Zimmerman RS, et al. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg (1991) 75(2):189-96. doi:10.3171/jns.1991.75.2.0189
33. van denBergh WM; MASH Study Group, Algra A, Dorhout Mees SM, van Kooten F, Dirven CM, et al. Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study. Stroke (2006) 37(9):2326-30. doi:10.1161/01.STR.0000236841.16055.0f
34. Wurm G, Tomancok B, Nussbaumer K, Adelwöhrer C, Holl K. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg (2004) 106(2):97-103. doi:10.1016/j.clineuro.2004.01.006
35. Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, et al. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg (2003) 99(6):953-9. doi:10.3171/jns.2003.99.6.0953
36. Haley EC, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg (1997) 86(3):467-74. doi:10.3171/jns.1997.86.3.0467
37. Lanzino G, Kassell NF. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg (1999) 90(6):1018-24. doi:10.3171/jns.1999.90.6.1018
38. van denBergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 36(5):1011-5. doi:10.1161/01.STR.0000160801.96998.57
39. Dorhout Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, Boiten J, et al. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet. 2012) 380(9836):44-9. doi:10.1016/S0140-6736(12)60724-7
40. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke (2008) 39(11):3015-21. doi:10.1161/STROKEAHA.108.519942
41. Shaw M, Vermeulen M, Murray GD, Pickard JD, Bell BA, Teasdale GM. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group. J Neurosurg (2000) 93(6):992-7. doi:10.3171/jns.2000.93.6.0992
42. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg (2005) 103(1):9-17. doi:10.3171/jns.2005.103.1.0009
43. Darby JM, Yonas H, Marks EC, Durham S, Snyder RW, Nemoto EM. Acute cerebral blood flow response to dopamine-induced hypertension after subarachnoid hemorrhage. J Neurosurg (1994) 80(5):857-64. doi:10.3171/jns.1994.80.5.0857
44. Muizelaar JP, Becker DP. Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage. Direct effect on cerebral blood flow. Surg Neurol (1986) 25(4):317-25. doi:10.1016/0090-3019(86)90205-3
45. Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke (2000) 31(2):383-91. doi:10.1161/01.STR.31.2.383
46. Egge A, Waterloo K, Sjøholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery (2001) 49(3):593-605. doi:10.1097/00006123-200109000-00012
47. Ekelund A, Reinstrup P, Ryding E, Andersson AM, Molund T, Kristiansson KA, et al. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) (2002;144(7):703-12. doi:10.1007/s00701-002-0959-9
48. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg (2004) 101(1):1-7. doi:10.3171/jns.2004.101.1.0001
49. Zubkov YN, Nikiforov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien) (1984) 70(1-2):65-79. doi:10.1007/BF01406044
50. Zwienenberg-Lee M, Hartman J, Rudisill N, Madden LK. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke (2008) 39(6):1759-65. doi:10.1161/STROKEAHA.107.502666
51. Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery (1999) 44(5):975-9. doi:10.1097/00006123-199905000-00022
52. Bejjani GK, Bank WO, Olan WJ, Sekhar LN. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery (1998) 42(5):979-86. doi:10.1097/00006123-199805000-00013
53. Kassell NF, Helm G, Simmons N, Phillips CD. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg (1992) 77(6):848-52. doi:10.3171/jns.1992.77.6.0848
54. Kimball MM, Velat GJ, Hoh BL; Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit Care (2011) 15:336-41. doi:10.1007/s12028-011-9600-1
55. Smith WS, Dowd CF, Johnston SC, Ko NU. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke (2004) 35(11):2518-22. doi:10.1161/01.STR.0000144682.00822.83
56. Keuskamp J, Murali R, Chao KH. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg (2008) 108(3):458-63. doi:10.3171/JNS/2008/108/3/0458
57. Feng L, Fitzsimmons BF, Young WL, Berman MF, Lin E, Aagaard BD, et al. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol (2002) 23(8):1284-90.
58. Linfante I, Delgado-Mederos R, Andreone V, Gounis M, Hendricks L, Wakhloo AK. Angiographic and hemodynamic effect of high concentration of intra-arterial nicardipine in cerebral vasospasm. Neurosurgery (2008) 63(6):1080-6. doi:10.1227/01.NEU.0000327698.66596.35
59. Badjatia N, Topcuoglu MA. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol (2004) 25(5):819-26.
60. Albanese E, Russo A, Quiroga M, Willis RN, Mericle RA, Ulm AJ. Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. Clinical article. J Neurosurg (2010) 113(4):913-22. doi:10.3171/2009.9.JNS0997
61. Aburto-Murrieta Y, Marquez-Romero JM. Endovascular treatment: balloon angioplasty versus nimodipine intra-arterial for medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Vasc Endovascular Surg (2012) 46(6):460-5. doi:10.1177/1538574412454585
62. Khatri R, Memon MZ, Zacharatos H, Taqui AM, Qureshi MH, Vazquez G, et al. Impact of percutaneous transluminal angioplasty for treatment of cerebral vasospasm on subarachnoid hemorrhage patient outcomes. Neurocrit Care (2011) 15(1):28-33. doi:10.1007/s12028-010-9499-y